Profarma Distribuidora Price To Book vs. Revenue
| PFRM3 Stock | BRL 6.00 0.11 1.80% |
For Profarma Distribuidora profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Profarma Distribuidora to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Profarma Distribuidora de utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Profarma Distribuidora's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Profarma Distribuidora de over time as well as its relative position and ranking within its peers.
Profarma |
Profarma Distribuidora Revenue vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Profarma Distribuidora's current stock value. Our valuation model uses many indicators to compare Profarma Distribuidora value to that of its competitors to determine the firm's financial worth. Profarma Distribuidora de is considered to be number one stock in price to book category among related companies. It is rated top company in revenue category among related companies totaling about 18,434,029,894 of Revenue per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value Profarma Distribuidora by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Profarma Distribuidora's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Profarma Distribuidora's earnings, one of the primary drivers of an investment's value.Profarma Revenue vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Profarma Distribuidora |
| = | 0.35 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Profarma Distribuidora |
| = | 6.41 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Profarma Revenue vs Competition
Profarma Distribuidora de is rated top company in revenue category among related companies. Market size based on revenue of Health Care industry is at this time estimated at about 123.19 Billion. Profarma Distribuidora holds roughly 6.41 Billion in revenue claiming about 5% of equities under Health Care industry.
Profarma Distribuidora Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Profarma Distribuidora, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Profarma Distribuidora will eventually generate negative long term returns. The profitability progress is the general direction of Profarma Distribuidora's change in net profit over the period of time. It can combine multiple indicators of Profarma Distribuidora, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Profarma Distrib Prod Farmaceuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil. PROFARMA operates under Medical Distribution classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 6327 people.
Profarma Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Profarma Distribuidora. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Profarma Distribuidora position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Profarma Distribuidora's important profitability drivers and their relationship over time.
Use Profarma Distribuidora in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Profarma Distribuidora position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profarma Distribuidora will appreciate offsetting losses from the drop in the long position's value.Profarma Distribuidora Pair Trading
Profarma Distribuidora de Pair Trading Analysis
The ability to find closely correlated positions to Profarma Distribuidora could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Profarma Distribuidora when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Profarma Distribuidora - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Profarma Distribuidora de to buy it.
The correlation of Profarma Distribuidora is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Profarma Distribuidora moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Profarma Distribuidora moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Profarma Distribuidora can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Profarma Distribuidora position
In addition to having Profarma Distribuidora in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Communication Services Thematic Idea Now
Communication Services
Companies that provide networking, telecom, and long distance services. The Communication Services theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Communication Services Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. Note that the Profarma Distribuidora information on this page should be used as a complementary analysis to other Profarma Distribuidora's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Profarma Stock analysis
When running Profarma Distribuidora's price analysis, check to measure Profarma Distribuidora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profarma Distribuidora is operating at the current time. Most of Profarma Distribuidora's value examination focuses on studying past and present price action to predict the probability of Profarma Distribuidora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profarma Distribuidora's price. Additionally, you may evaluate how the addition of Profarma Distribuidora to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
To fully project Profarma Distribuidora's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Profarma Distribuidora at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Profarma Distribuidora's income statement, its balance sheet, and the statement of cash flows.